What was the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing was to publicly announce that CVS Corporation had priced a $1.2 billion private placement of unsecured senior notes.

What are the key terms of the notes issued?

The senior notes have maturities of 5 and 10 years. Specific details regarding interest rates, redemption provisions, and other covenants would be found in the press release (Exhibit 99.1) attached to this filing.

How does this debt issuance impact CVS financially?

This $1.2 billion debt issuance increases CVS's leverage and will result in future interest expense. Investors should analyze the terms in the press release to understand the cost of this debt and its potential impact on the company's financial flexibility and profitability.

Who signed the report, and what does that signify?

The report was signed by David B. Rickard, Executive Vice President, Chief Financial Officer, and Chief Administrative Officer. This indicates that the issuance and reporting of this significant financial event were overseen and authorized by the company's senior finance executive.

CVS 8-K SEC Disclosure — Sep 10, 2004

Summary

CVS Corporation (CVS) filed an 8-K report on September 9, 2004, to announce the pricing of a significant private placement of senior notes. The company successfully raised $1.2 billion through the issuance of unsecured notes with maturities of 5 and 10 years. This capital infusion is a key event for investors, signaling strategic financial management and potentially funding for growth initiatives or debt restructuring. The details of this note issuance, including the specific interest rates and terms, would be further elaborated in the referenced press release (Exhibit 99.1). Investors should review this press release for a comprehensive understanding of the financial implications, such as the cost of this debt and its impact on CVS's leverage ratios and future interest expense.

Key Highlights

1CVS Corporation priced a $1.2 billion private placement of unsecured senior notes.
2The notes have maturities of both 5 and 10 years.
3This filing was made on September 9, 2004, reporting an event from September 8, 2004.
4The announcement is made via a press release attached as Exhibit 99.1.
5The Chief Financial Officer, David B. Rickard, signed the report, indicating CFO-level oversight.
6The debt issuance suggests a strategic move to secure long-term financing.

CVS HEALTH Corp 8-K Report, Corporate Update (Sep 10, 2004)

Summary

Key Highlights

Frequently Asked Questions